Phase 3 Multi-Center Double-Blind Randomized Placebo-Controlled Effectiveness and Safety Study to Assess the Role of Truvada in Preventing HIV Acquisition in Women.

Trial Profile

Phase 3 Multi-Center Double-Blind Randomized Placebo-Controlled Effectiveness and Safety Study to Assess the Role of Truvada in Preventing HIV Acquisition in Women.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2017

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
  • Indications HIV-1 infections; HIV-2 infections
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms FEM-PrEP
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 10 Mar 2016 Results of a sub-group analysis from kenyan participants (n=62) published in the Contraception
    • 11 Jul 2012 Results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top